Corvivo Cardiovascular, Inc.
Clinical trials sponsored by Corvivo Cardiovascular, Inc., explained in plain language.
-
New heart valve could transform tricuspid treatment
Disease control Recruiting nowThis study is testing a new valve (Cor TRICUSPID ECM Valve) for people with tricuspid heart valve disease. About 92 adults and children will receive the valve during surgery and be followed for up to 5 years. The goal is to see if the valve is safe and works well to fix the damag…
Phase: NA • Sponsor: Corvivo Cardiovascular, Inc. • Aim: Disease control
Last updated May 26, 2026 11:59 UTC
-
New heart valve could change tricuspid surgery
Disease control Recruiting nowThis study is testing a new type of heart valve (the Cor TRICUSPID ECM Valve) for people who need their tricuspid valve replaced. The valve is made from a special material that may help the body heal. The study will check if the valve is safe and works well. About 78 people will …
Phase: NA • Sponsor: Corvivo Cardiovascular, Inc. • Aim: Disease control
Last updated May 22, 2026 14:03 UTC